Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobuhito Hirawa

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 17, 2023
Blood pressure management in hemodialysis patientsNobuhito Hirawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 15, 2004
[Prostaglandin/bradykinin]Nobuhito Hirawa, Satoshi Umemura
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 9, 2005
[The gene, synthesis, function of kallikrein]Nobuhito Hirawa, Satoshi Umemura
Blood Pressure|October 15, 2015
Relation between circadian blood pressure rhythm and serum albumin level in non-diabetic patients with proteinuriaDaisaku Ando, Nobuhito Hirawa, Gen Yasuda
Circulation Research|March 29, 2019
Viewpoint on Guidelines for Treatment of Hypertension in JapanNobuhito Hirawa, Satoshi Umemura, Sadayoshi Ito
Hypertension Research : Official Journal of the Japanese Society of Hypertension|January 9, 2026
Advancing evidence-based blood pressure targets in JSH2025Atsushi Sakima, Nobuhito Hirawa, Yusuke Ohya
Current Opinion in Nephrology and Hypertension|January 18, 2013
ATP2B1 and blood pressure: from associations to pathophysiologyNobuhito Hirawa, Akira Fujiwara, Satoshi Umemura
Renal Failure|June 15, 2010
Effects of atorvastatin versus probucol on low-density lipoprotein subtype distribution and renal function in hyperlipidemic patients with nondiabetic nephropathyGen Yasuda, Daisaku Ando, Nobuhito Hirawa, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|May 29, 2014
Effects of doxazosin as the third agent on morning hypertension and position-related blood pressure changes in diabetic patients with chronic kidney diseaseGen Yasuda, Sanae Saka, Daisaku Ando, et al.
Kidney & Blood Pressure Research|October 26, 2012
Effects of carvedilol as third-line add-on therapy on blood pressure and glucose metabolism in type 2 diabetic patients with chronic renal disease stage 3 and aboveGen Yasuda, Keisuke Yatsu, Yuichiro Yamamoto, et al.
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 17, 2023
Blood pressure management in hemodialysis patientsNobuhito Hirawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 15, 2004
[Prostaglandin/bradykinin]Nobuhito Hirawa, Satoshi Umemura
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 9, 2005
[The gene, synthesis, function of kallikrein]Nobuhito Hirawa, Satoshi Umemura
Blood Pressure|October 15, 2015
Relation between circadian blood pressure rhythm and serum albumin level in non-diabetic patients with proteinuriaDaisaku Ando, Nobuhito Hirawa, Gen Yasuda
Circulation Research|March 29, 2019
Viewpoint on Guidelines for Treatment of Hypertension in JapanNobuhito Hirawa, Satoshi Umemura, Sadayoshi Ito
Hypertension Research : Official Journal of the Japanese Society of Hypertension|January 9, 2026
Advancing evidence-based blood pressure targets in JSH2025Atsushi Sakima, Nobuhito Hirawa, Yusuke Ohya
Current Opinion in Nephrology and Hypertension|January 18, 2013
ATP2B1 and blood pressure: from associations to pathophysiologyNobuhito Hirawa, Akira Fujiwara, Satoshi Umemura
Renal Failure|June 15, 2010
Effects of atorvastatin versus probucol on low-density lipoprotein subtype distribution and renal function in hyperlipidemic patients with nondiabetic nephropathyGen Yasuda, Daisaku Ando, Nobuhito Hirawa, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|May 29, 2014
Effects of doxazosin as the third agent on morning hypertension and position-related blood pressure changes in diabetic patients with chronic kidney diseaseGen Yasuda, Sanae Saka, Daisaku Ando, et al.
Kidney & Blood Pressure Research|October 26, 2012
Effects of carvedilol as third-line add-on therapy on blood pressure and glucose metabolism in type 2 diabetic patients with chronic renal disease stage 3 and aboveGen Yasuda, Keisuke Yatsu, Yuichiro Yamamoto, et al.
Pageof 9